Dolorgiet (CNS portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Dolorgiet (CNS portfolio) General Information

Description

Portfolio of medical drugs. The portfolio consists of drug brands used in several areas of treatment including antidepressant, anti-migraine treatment, depressive disorders, obsessive compulsive disorders, phobias and panic disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Germany
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Riemser Pharma
Corporate Office
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dolorgiet (CNS portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dolorgiet (CNS portfolio)‘s full profile, request access.

Request a free trial

Dolorgiet (CNS portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dolorgiet (CNS portfolio)‘s full profile, request access.

Request a free trial

Dolorgiet (CNS portfolio) FAQs

  • Where is Dolorgiet (CNS portfolio) headquartered?

    Dolorgiet (CNS portfolio) is headquartered in Germany.

  • What industry is Dolorgiet (CNS portfolio) in?

    Dolorgiet (CNS portfolio)’s primary industry is Buildings and Property.

  • Is Dolorgiet (CNS portfolio) a private or public company?

    Dolorgiet (CNS portfolio) is a Private company.

  • What is Dolorgiet (CNS portfolio)’s current revenue?

    The current revenue for Dolorgiet (CNS portfolio) is 000000.

  • Who are Dolorgiet (CNS portfolio)’s investors?

    Dolorgiet has invested in Dolorgiet (CNS portfolio).

  • When was Dolorgiet (CNS portfolio) acquired?

    Dolorgiet (CNS portfolio) was acquired on 05-Sep-2016.

  • Who acquired Dolorgiet (CNS portfolio)?

    Dolorgiet (CNS portfolio) was acquired by Riemser Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »